Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Current Cardiovascular Imaging Reports
Published in: Current Cardiovascular Imaging Reports 4/2011

01-08-2011 | Clinical Trial Report

Test the Heart Nerves: True Grit for Prognosis?

Authors: Marcus V. Simões, J. Antonio Marin-Neto

Published in: Current Cardiovascular Imaging Reports | Issue 4/2011

Login to get access

Excerpt

Jacobson AF, Senior R, Cerqueira MD, et al.; on behalf of the ADMIRE-HF Investigators: Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. J Am Coll Cardiol 2010, 55:2212–2221. …
Literature
1.
Kline RC, Swanson DP, Wieland DM, et al. Myocardial imaging in man with I-123 meta-iodobenzylguanidine. J Nucl Med. 1981;22:129–32.PubMed
2.
Cohn JN, Levine TB, Olivari MT, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984;311:819–23.PubMedCrossRef
3.
Merlet P, Valette H, Dubois-Randle JL, et al. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med. 1992;33:471–7.PubMed
4.
Verberne HJ, Brewster LM, Somsen GA, Van Eck-Smit BLF. Prognostic value of myocardial 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: a systematic review. Eur Heart J. 2008;29:1147–59.PubMedCrossRef
5.
Agostini D, Verberne HJ, Burchert W, et al. I-123-mIBG myocardial imaging for assessment of risk for a major cardiac event in heart failure patients: insights from a retrospective European multicenter study. Eur J Nucl Med Mol Imaging. 2008;35:535–46.PubMedCrossRef
6.
Simões MV, Barthel P, Matsunari I, Nekolla SG, Schömig A, Schwaiger M, et al. Presence of sympathetically denervated but viable myocardium and its electrophysiologic correlates after early revascularised, acute myocardial infarction. Eur Heart J. 2004;25(7):551–7.PubMedCrossRef
7.
Bax JJ, Kraft O, Buxon AE, et al. 123I-mIBG scintigraphy to predict inducibility of ventricular arrhythmias on cardiac alectrophysiology testing: a prospective multicenter pilot study. Circ Cadiovasc Imaging. 2008;1:131–40.CrossRef
8.
Nagarahara D, Nakata T, Hashimoto A, et al. Predicting the need for an implantable cardioverter defibrillator using cardiac metaiodobenzylguanidine activity together with plasma natriuretic peptide concentration or left ventricular function. J Nucl Med. 2008;49:225–33.CrossRef
9.
Flotats A, Carrió I, Agostini D, Le Guludec D, Marcassa C, Schaffers M, et al. Proposal for standadization of 123-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology. Eur J Nucl Med Mol Imaging. 2010;37:1802–12.PubMedCrossRef
10.
Simões MV, Pintya AO, Bromberg-Marin G, Sarabanda AV, Antloga CM, Pazin-Filho A, et al. Relation of regional sympathetic denervation and myocardial perfusion disturbance to wall motion impairment in Chagas’ cardiomyopathy. Am J Cardiol. 2000;86(9):975–81.PubMedCrossRef
Metadata
Title
Test the Heart Nerves: True Grit for Prognosis?
Authors
Marcus V. Simões
J. Antonio Marin-Neto
Publication date
01-08-2011
Publisher
Current Science Inc.
Published in
Current Cardiovascular Imaging Reports / Issue 4/2011
Print ISSN: 1941-9066
Electronic ISSN: 1941-9074
DOI
https://doi.org/10.1007/s12410-011-9094-4

Other articles of this Issue 4/2011

Current Cardiovascular Imaging Reports 4/2011 Go to the issue

ReviewPaper

Optical Coherence Tomography and Fibrous Cap Characterization

ReviewPaper

Insights from CTA with Comparison to Modalities of Intravascular Ultrasound Imaging

ReviewPaper

Intravascular Imaging in Patients with Acute Coronary Syndromes and Unstable Coronary Plaques

ReviewPaper

Angioscopy and Unstable Coronary Plaques: Findings Beyond Thrombus

ReviewPaper

Recent Advances in Percutaneous Cardioscopy

ReviewPaper

Assessment of Plaque Composition with Near-Infrared Spectroscopy

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits